Mumbai, Sept. 30 -- The scrip was listed at Rs 80.80, a premium of 15.43% over the initial public offer (IPO) price. The stock is currently up 3.96% over its listing price.

The counter hit a high of Rs 84.84 and a low of Rs 80.80. About 8.18 lakh shares of the company changed hands at the counter.

Aptus Pharma's IPO was subscribed 20.79 times. The issue opened for bidding on 23 September 2025 and it closed on 25 September 2025. The price band of the IPO was fixed between Rs 65 to 70 per share.

The IPO comprised fresh issue of 18,60,000 equity shares. The promoter and promoter group shareholding will diluted to 72.89% from 100% pre-issue.

The company intends to utilize the net proceeds for capital expenditure for office premises with f...